In Vitro Characterization of Vilazodone as a Dual-Acting Serotonin Reuptake Inhibitor and 5-HT1A Receptor Partial Agonist

被引：0
|
作者：
Kehne, John H. [1 ]
Bartoszyk, Gerd D. [2 ]
Greiner, Hartmut E. [2 ]
Pierz, Kerri A. [3 ]
Renda, Matthew J. [3 ]
van Amsterdam, Christoph [2 ]
Reed, Carol R. [3 ]
Athanasiou, Maria C. [3 ]
机构：
[1] Translat Neuropharmacol Consulting LLC, Execut, Rockville, MD USA
[2] Merck KGaA, Preclin Pharmaceut Res, Darmstadt, Germany
[3] PGxHealth LLC, Div Clin Data, Med Affairs, New Haven, CT USA
来源：
BIOLOGICAL PSYCHIATRY | 2010年 / 67卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
821
引用
收藏
页码：237S / 237S
页数：1
相关论文
共 50 条
  • [21] Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists
    Gary, David L.
    Xu, Wenjian
    Campbell, Brian M.
    Dounay, Amy B.
    Barta, Nancy
    Boroski, Susan
    Denny, Lynne
    Evans, Lori
    Stratman, Nancy
    Probert, Al
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (23) : 6604 - 6607
  • [22] Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors
    NewmanTancredi, A
    Chaput, C
    Verriele, L
    Millan, MJ
    NEUROPHARMACOLOGY, 1996, 35 (01) : 119 - 121
  • [23] Identification of serotonin 5-HT1A receptor partial agonists in ginger
    Nievergelt, Andreas
    Huonker, Peter
    Schoop, Roland
    Altmann, Karl-Heinz
    Gertsch, Juerg
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (09) : 3345 - 3351
  • [24] Anti-PTSD Effects of Hypidone Hydrochloride (YL-0919): A Novel Combined Selective 5-HT Reuptake Inhibitor/5-HT1A Receptor Partial Agonist/5-HT6 Receptor Full Agonist
    Liu, Wen-Gang
    Zhang, Li-Ming
    Yao, Jun-Qi
    Yin, Yong-Yu
    Zhang, Xiao-Ying
    Li, Yun-Feng
    Cao, Jiang-Bei
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [25] 5-HT1A/1B Receptor-Mediated Effects of the Selective Serotonin Reuptake Inhibitor, Citalopram, on Sleep: Studies in 5-HT1A and 5-HT1B Knockout Mice
    Christelle Monaca
    Benjamin Boutrel
    René Hen
    Michel Hamon
    Joëlle Adrien
    Neuropsychopharmacology, 2003, 28 : 850 - 856
  • [26] 5-HT1A/1B receptor-mediated effects of the selective serotonin reuptake inhibitor, citalopram, on sleep:: Studies in 5-HT1A and 5-HT1B knockout mice
    Monaca, C
    Boutrel, B
    Hen, R
    Hamon, M
    Adrien, J
    NEUROPSYCHOPHARMACOLOGY, 2003, 28 (05) : 850 - 856
  • [27] The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor
    Jordan, S
    Koprivica, V
    Chen, RY
    Tottori, K
    Kikuchi, T
    Altar, CA
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 441 (03) : 137 - 140
  • [28] Effects of systemic injections of Vilazodone, a selective serotonin reuptake inhibitor and serotonin 1A receptor agonist, on anxiety induced by predator stress in rats
    Adamec, R
    Bartoszyk, GD
    Burton, P
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 504 (1-2) : 65 - 77
  • [29] Improving voiding efficiency in the diabetic rat by a 5-HT1A serotonin receptor agonist
    Gu, Baojun
    Wu, Gang
    Si, Jieming
    Xu, Yuemin
    Andersson, Karl-Erik
    NEUROUROLOGY AND URODYNAMICS, 2012, 31 (01) : 168 - 173
  • [30] Catalepsy induced by the 5-HT1A receptor antagonist WAY 100635 in rats pretreated with the selective serotonin reuptake inhibitor citalopram
    Eltayb, A
    Svensson, TH
    Ahlenius, S
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 411 (03) : 275 - 277
12345